BRIEF published on 04/04/2025 at 15:00, 1 year 4 months ago EUROPLASMA: Information on voting rights and capital shares Share Capital Voting Rights Europlasma Euronext Growth Shares Outstanding
BRIEF published on 04/04/2025 at 14:59, 1 year 4 months ago EUROPLASMA : Bilan des droits de vote et actions au 31 mars 2025 Droits De Vote Capital Social Europlasma Euronext Growth Actions En Circulation
BRIEF published on 04/04/2025 at 14:59, 1 year 4 months ago EUROPLASMA: Balance sheet of voting rights and shares as of March 31, 2025 Share Capital Voting Rights Outstanding Shares Europlasma Euronext Growth
PRESS RELEASE published on 04/04/2025 at 14:55, 1 year 4 months ago EUROPLASMA: Information relative au nombre total de droits de vote et d’actions composant le capital au 31 mars 2025 EUROPLASMA déclare le nombre total de droits de vote et d'actions au 31 mars 2025, conformément à la réglementation financière Droits De Vote Capital Social Actions Europlasma Finance
PRESS RELEASE published on 04/04/2025 at 14:54, 1 year 4 months ago EUROPLASMA: Information relative au nombre total de droits de vote et d’actions composant le capital au 31 mars 2025 EUROPLASMA communique le nombre total de droits de vote et d'actions au 31 mars 2025 conformément à la réglementation Capital Droits De Vote Actions Europlasma Circulation
BRIEF published on 03/31/2025 at 18:20, 1 year 4 months ago Europlasma procède au tirage du troisième Investor Call Financement Obligations Convertibles Europlasma Décarbonation Dilution Actionnaire
BRIEF published on 03/31/2025 at 18:20, 1 year 4 months ago Europlasma proceeds with the drawing of the third Investor Call Decarbonization Convertible Bonds Shareholder Dilution Funding Europlasma
PRESS RELEASE published on 03/31/2025 at 18:15, 1 year 4 months ago EUROPLASMA: EXERCICE DU TROISIÈME INVESTOR CALL Europlasma annonce le tirage de la huitième tranche d'obligations convertibles pour financer sa croissance. Détails sur les activités soutenues et les risques associés Croissance Obligations Convertibles Europlasma Risques Tirage
BRIEF published on 03/19/2025 at 19:05, 1 year 4 months ago Europlasma lance la septième tranche d'obligations convertibles Obligations Convertibles Europlasma Dilution Croissance Stratégique Investissement Industriel
BRIEF published on 03/19/2025 at 19:05, 1 year 4 months ago Europlasma launches the seventh tranche of convertible bonds Convertible Bonds Europlasma Strategic Growth Dilution Industrial Investment
Published on 08/10/2026 at 11:00, 16 minutes ago Blue Lagoon Announces C$10 Million Strategic Investment by Nicola Mining and Ocean Partners
Published on 08/10/2026 at 08:00, 3 hours 16 minutes ago Galantas Gold Expands Indiana Drill Program to 12,500 Metres
Published on 08/10/2026 at 08:00, 3 hours 16 minutes ago Results of AGM and Management Update Presentation
Published on 08/07/2026 at 23:15, 2 days 12 hours ago Faraday Copper Reports Second Quarter 2026 Financial Results
Published on 08/10/2026 at 10:12, 1 hour 4 minutes ago Turkiye Garanti Bankasi A.S.: CMB Approval for Bond Issuance to Foreign Markets
Published on 08/10/2026 at 10:10, 1 hour 6 minutes ago Hana Bank Subsidiary GLN Expands QR Payment Network for International Travelers to Korea
Published on 08/10/2026 at 09:50, 1 hour 26 minutes ago Photon Energy N.V. Bond 21/27 (ISIN: DE000A3KWKY4): Signs of a crisis are mounting. What can investors do? Invitation to video conferences (German/English)
Published on 08/10/2026 at 09:00, 2 hours 16 minutes ago Original-Research: Rosenbauer International AG (von NuWays AG): BUY
Published on 08/10/2026 at 09:47, 1 hour 29 minutes ago 260810 BENETEAU Transactions sur actions propres
Published on 08/10/2026 at 09:22, 1 hour 54 minutes ago Number of shares and voting rights - July 2026 (In French only)
Published on 08/10/2026 at 09:22, 1 hour 54 minutes ago Nombre total d'actions et droits de vote - juillet 2026
Published on 08/10/2026 at 07:00, 4 hours 16 minutes ago BIOPHYTIS ANNOUNCES APPROVAL OF THE OBA CLINICAL TRIAL IN BRAZIL AND SHARES ITS OUTLOOK FOR BIO101 IN OBESITY
Published on 08/10/2026 at 07:00, 4 hours 16 minutes ago Biophytis annonce l’autorisation de l’étude clinique OBA au Brésil et partage les perspectives de BIO101 dans l’obésité
